Successful Treatment of HLH in Oman
The University Medical City announced the successful treatment of a child with the rare genetic disorder Hemophagocytic Lymphohistiocytosis (HLH), for the first time in the Sultanate of Oman.
According to the Medical City’s account on the “X” platform, HLH syndrome usually leads to inevitable death, and the child was treated using the modern immunotherapy drug EMAPALUMAB as an alternative to chemotherapy, in preparation for a bone marrow transplant at the Oman National Center for Blood Diseases and Bone Marrow Transplantation at the University Medical City.
The Medical City explained that the treatment was carried out by a joint specialized medical team from the Child Health Department and the Hematology Department at Sultan Qaboos University Hospital and the Oman National Center for Blood Diseases and Bone Marrow Transplantation at the University Medical City.
